Showing the single result
Rasagiline Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly sensitive mesylate salt.
Active Ingredient Strength Primary Clinical Function Rasagiline Mesylate INN/Ph.Eur. 0.5 mg (Base Equivalent) Adjunct Standard: Initiating dose when used in combination with Levodopa. Rasagiline Mesylate INN/Ph.Eur. 1 mg (Base Equivalent) Global Clinical Standard: Maximum daily dose for monotherapy or advanced adjunct therapy. Excipients Mannitol / Maize Starch / Pregelatinized Starch / Colloidal Silicon Dioxide / Stearic Acid Diluent / Binder / Superdisintegrant / Glidant (Engineered for immediate gastric dissolution and rapid crossing of the blood-brain barrier) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict high-compliance 30-day chronic neurology dispensing regimens).
